Abstract

Chimeric antigen receptor T-cells (CAR-T) generated from autologous T-cells of patients with B-cell malignancies can induce durable remission, but this

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call